Loading…
Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife
PurposeFor the treatment of invisible lung tumours with CyberKnife (CK), fiducial markers (FMs) were implanted as an internal surrogate under virtual bronchoscopic navigation (VBN). This research aims to study the benefits of introducing an additional procedure in assigning the optimal FM positions...
Saved in:
Published in: | Frontiers in oncology 2022-06, Vol.12, p.860641-860641 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c392t-247356141695ea6fe8a88b39bee82f21435dd29a2c99d487418af596ac4a111a3 |
container_end_page | 860641 |
container_issue | |
container_start_page | 860641 |
container_title | Frontiers in oncology |
container_volume | 12 |
creator | Ku, Ki Man Lam, Bing Wu, Vincent W. C. Chan, Kwok Ting Chan, Chloe Y. Y. Cheng, H. C. Yuen, Kamy M. Y. Cai, Jing |
description | PurposeFor the treatment of invisible lung tumours with CyberKnife (CK), fiducial markers (FMs) were implanted as an internal surrogate under virtual bronchoscopic navigation (VBN). This research aims to study the benefits of introducing an additional procedure in assigning the optimal FM positions using a pre-procedure planning system and performing virtual simulation before implantation. The objectives were 1) to reduce the duration of the FM implantation procedure, 2) to reduce the radiation exposure in dose area product (DAP) (dGy*cm2) to patients, and 3) to increase the number of FMs implanted around the tumour. Methods and MaterialsThis study is retrospective, single-centre, and observational in nature. A total of 32 patients were divided into two groups. In Group 1, 18 patients underwent conventional VBN FM implantation. In Group 2, 14 patients underwent additional pre-procedure planning and simulation. The steps of pre-procedure planning include 1) importing CT images into the treatment planning system (Eclipse, Varian Medical Systems, Inc.) and delineating five to six FMs in their ideal virtual positions and 2) copying the FM configuration into VBN planning software (LungPoint Bronchus Medical, Inc.) for verification and simulation. Finally, the verified FMs were deployed through VBN with the guidance of the LungPoint planning software. ResultsA total of 162 FMs were implanted among 35 lesions in 32 patients aged from 37 to 92 (median = 66; 16 men and 16 women). Results showed that 1) the average FM insertion time was shortened from 41 min (SD = 2.05) to 23 min (SD = 1.25), p = 0.00; 2) the average absorbed dose of patients in DAP was decreased from 67.4 cGy*cm2 (SD = 14.48) to 25.3 cGy*cm2 (SD = 3.82), p = 0.01 (1-tailed); and 3) the average number of FMs implanted around the tumour was increased from 4.7 (SD = 0.84) to 5.6 (SD = 0.76), p = 0.00 (1-tailed). ConclusionPre-procedure planning reduces the FM implantation duration from 41.1 to 22.9 min, reduces the radiation exposure in DAP from 67.4 to 25.3 dGy*cm2, and increases the number of FMs inserted around the tumour from 4.7 to 5.6. |
doi_str_mv | 10.3389/fonc.2022.860641 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_56c7fc4a27424e7cb3f464341229aa15</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_56c7fc4a27424e7cb3f464341229aa15</doaj_id><sourcerecordid>2685031867</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-247356141695ea6fe8a88b39bee82f21435dd29a2c99d487418af596ac4a111a3</originalsourceid><addsrcrecordid>eNpVkstu3CAUhq2qUROl2XfJshtPzcUYNpXaUdKOMk2ymF526BjDDKkNU7BHyoPkfcvUUZWwAc75z3e4_EXxDlcLSoX8YIPXC1IRshC84gy_Ks4IoayUjP56_Wx9WlykdF_lwesKV_RNcUrrRtS4EWfF47J33mno0eUB-glGFzwKFl25btIuh79B_G0iuoumvOvBe-e3yIaIfrg4Tjn_OeZj7ELSYe80uoGD286Q1bDP-nHeOI_WU67cTEOYMi1HjR8T2kQDo-nQTzfu0PKhNfHaO2veFicW-mQunubz4vvV5Wb5tVzfflktP61LTSUZS8IaWnPMMJe1AW6NACFaKltjBLEEM1p3HZFAtJQdEw3DAmwtOWgGGGOg58Vq5nYB7tU-ugHigwrg1L9AiFsFcXS6N6rmurG5jjSMMNPollrGGWWY5AaA68z6OLP2UzuYTuf7RehfQF9mvNupbTgoSVj-GJoB758AMfyZTBrV4JI2fX5FE6akCBdZhgVvsrSapTqGlKKx_9vgSh3NoY7mUEdzqNkc9C-FkK6v</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2685031867</pqid></control><display><type>article</type><title>Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife</title><source>PMC (PubMed Central)</source><creator>Ku, Ki Man ; Lam, Bing ; Wu, Vincent W. C. ; Chan, Kwok Ting ; Chan, Chloe Y. Y. ; Cheng, H. C. ; Yuen, Kamy M. Y. ; Cai, Jing</creator><creatorcontrib>Ku, Ki Man ; Lam, Bing ; Wu, Vincent W. C. ; Chan, Kwok Ting ; Chan, Chloe Y. Y. ; Cheng, H. C. ; Yuen, Kamy M. Y. ; Cai, Jing</creatorcontrib><description>PurposeFor the treatment of invisible lung tumours with CyberKnife (CK), fiducial markers (FMs) were implanted as an internal surrogate under virtual bronchoscopic navigation (VBN). This research aims to study the benefits of introducing an additional procedure in assigning the optimal FM positions using a pre-procedure planning system and performing virtual simulation before implantation. The objectives were 1) to reduce the duration of the FM implantation procedure, 2) to reduce the radiation exposure in dose area product (DAP) (dGy*cm2) to patients, and 3) to increase the number of FMs implanted around the tumour. Methods and MaterialsThis study is retrospective, single-centre, and observational in nature. A total of 32 patients were divided into two groups. In Group 1, 18 patients underwent conventional VBN FM implantation. In Group 2, 14 patients underwent additional pre-procedure planning and simulation. The steps of pre-procedure planning include 1) importing CT images into the treatment planning system (Eclipse, Varian Medical Systems, Inc.) and delineating five to six FMs in their ideal virtual positions and 2) copying the FM configuration into VBN planning software (LungPoint Bronchus Medical, Inc.) for verification and simulation. Finally, the verified FMs were deployed through VBN with the guidance of the LungPoint planning software. ResultsA total of 162 FMs were implanted among 35 lesions in 32 patients aged from 37 to 92 (median = 66; 16 men and 16 women). Results showed that 1) the average FM insertion time was shortened from 41 min (SD = 2.05) to 23 min (SD = 1.25), p = 0.00; 2) the average absorbed dose of patients in DAP was decreased from 67.4 cGy*cm2 (SD = 14.48) to 25.3 cGy*cm2 (SD = 3.82), p = 0.01 (1-tailed); and 3) the average number of FMs implanted around the tumour was increased from 4.7 (SD = 0.84) to 5.6 (SD = 0.76), p = 0.00 (1-tailed). ConclusionPre-procedure planning reduces the FM implantation duration from 41.1 to 22.9 min, reduces the radiation exposure in DAP from 67.4 to 25.3 dGy*cm2, and increases the number of FMs inserted around the tumour from 4.7 to 5.6.</description><identifier>ISSN: 2234-943X</identifier><identifier>EISSN: 2234-943X</identifier><identifier>DOI: 10.3389/fonc.2022.860641</identifier><identifier>PMID: 35785178</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>CyberKnife ; dose area product ; fiducial marker ; lung cancer ; Oncology ; virtual bronchoscopic navigation</subject><ispartof>Frontiers in oncology, 2022-06, Vol.12, p.860641-860641</ispartof><rights>Copyright © 2022 Ku, Lam, Wu, Chan, Chan, Cheng, Yuen and Cai 2022 Ku, Lam, Wu, Chan, Chan, Cheng, Yuen and Cai</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c392t-247356141695ea6fe8a88b39bee82f21435dd29a2c99d487418af596ac4a111a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246503/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246503/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27915,27916,53782,53784</link.rule.ids></links><search><creatorcontrib>Ku, Ki Man</creatorcontrib><creatorcontrib>Lam, Bing</creatorcontrib><creatorcontrib>Wu, Vincent W. C.</creatorcontrib><creatorcontrib>Chan, Kwok Ting</creatorcontrib><creatorcontrib>Chan, Chloe Y. Y.</creatorcontrib><creatorcontrib>Cheng, H. C.</creatorcontrib><creatorcontrib>Yuen, Kamy M. Y.</creatorcontrib><creatorcontrib>Cai, Jing</creatorcontrib><title>Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife</title><title>Frontiers in oncology</title><description>PurposeFor the treatment of invisible lung tumours with CyberKnife (CK), fiducial markers (FMs) were implanted as an internal surrogate under virtual bronchoscopic navigation (VBN). This research aims to study the benefits of introducing an additional procedure in assigning the optimal FM positions using a pre-procedure planning system and performing virtual simulation before implantation. The objectives were 1) to reduce the duration of the FM implantation procedure, 2) to reduce the radiation exposure in dose area product (DAP) (dGy*cm2) to patients, and 3) to increase the number of FMs implanted around the tumour. Methods and MaterialsThis study is retrospective, single-centre, and observational in nature. A total of 32 patients were divided into two groups. In Group 1, 18 patients underwent conventional VBN FM implantation. In Group 2, 14 patients underwent additional pre-procedure planning and simulation. The steps of pre-procedure planning include 1) importing CT images into the treatment planning system (Eclipse, Varian Medical Systems, Inc.) and delineating five to six FMs in their ideal virtual positions and 2) copying the FM configuration into VBN planning software (LungPoint Bronchus Medical, Inc.) for verification and simulation. Finally, the verified FMs were deployed through VBN with the guidance of the LungPoint planning software. ResultsA total of 162 FMs were implanted among 35 lesions in 32 patients aged from 37 to 92 (median = 66; 16 men and 16 women). Results showed that 1) the average FM insertion time was shortened from 41 min (SD = 2.05) to 23 min (SD = 1.25), p = 0.00; 2) the average absorbed dose of patients in DAP was decreased from 67.4 cGy*cm2 (SD = 14.48) to 25.3 cGy*cm2 (SD = 3.82), p = 0.01 (1-tailed); and 3) the average number of FMs implanted around the tumour was increased from 4.7 (SD = 0.84) to 5.6 (SD = 0.76), p = 0.00 (1-tailed). ConclusionPre-procedure planning reduces the FM implantation duration from 41.1 to 22.9 min, reduces the radiation exposure in DAP from 67.4 to 25.3 dGy*cm2, and increases the number of FMs inserted around the tumour from 4.7 to 5.6.</description><subject>CyberKnife</subject><subject>dose area product</subject><subject>fiducial marker</subject><subject>lung cancer</subject><subject>Oncology</subject><subject>virtual bronchoscopic navigation</subject><issn>2234-943X</issn><issn>2234-943X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkstu3CAUhq2qUROl2XfJshtPzcUYNpXaUdKOMk2ymF526BjDDKkNU7BHyoPkfcvUUZWwAc75z3e4_EXxDlcLSoX8YIPXC1IRshC84gy_Ks4IoayUjP56_Wx9WlykdF_lwesKV_RNcUrrRtS4EWfF47J33mno0eUB-glGFzwKFl25btIuh79B_G0iuoumvOvBe-e3yIaIfrg4Tjn_OeZj7ELSYe80uoGD286Q1bDP-nHeOI_WU67cTEOYMi1HjR8T2kQDo-nQTzfu0PKhNfHaO2veFicW-mQunubz4vvV5Wb5tVzfflktP61LTSUZS8IaWnPMMJe1AW6NACFaKltjBLEEM1p3HZFAtJQdEw3DAmwtOWgGGGOg58Vq5nYB7tU-ugHigwrg1L9AiFsFcXS6N6rmurG5jjSMMNPollrGGWWY5AaA68z6OLP2UzuYTuf7RehfQF9mvNupbTgoSVj-GJoB758AMfyZTBrV4JI2fX5FE6akCBdZhgVvsrSapTqGlKKx_9vgSh3NoY7mUEdzqNkc9C-FkK6v</recordid><startdate>20220616</startdate><enddate>20220616</enddate><creator>Ku, Ki Man</creator><creator>Lam, Bing</creator><creator>Wu, Vincent W. C.</creator><creator>Chan, Kwok Ting</creator><creator>Chan, Chloe Y. Y.</creator><creator>Cheng, H. C.</creator><creator>Yuen, Kamy M. Y.</creator><creator>Cai, Jing</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220616</creationdate><title>Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife</title><author>Ku, Ki Man ; Lam, Bing ; Wu, Vincent W. C. ; Chan, Kwok Ting ; Chan, Chloe Y. Y. ; Cheng, H. C. ; Yuen, Kamy M. Y. ; Cai, Jing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-247356141695ea6fe8a88b39bee82f21435dd29a2c99d487418af596ac4a111a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>CyberKnife</topic><topic>dose area product</topic><topic>fiducial marker</topic><topic>lung cancer</topic><topic>Oncology</topic><topic>virtual bronchoscopic navigation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ku, Ki Man</creatorcontrib><creatorcontrib>Lam, Bing</creatorcontrib><creatorcontrib>Wu, Vincent W. C.</creatorcontrib><creatorcontrib>Chan, Kwok Ting</creatorcontrib><creatorcontrib>Chan, Chloe Y. Y.</creatorcontrib><creatorcontrib>Cheng, H. C.</creatorcontrib><creatorcontrib>Yuen, Kamy M. Y.</creatorcontrib><creatorcontrib>Cai, Jing</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ku, Ki Man</au><au>Lam, Bing</au><au>Wu, Vincent W. C.</au><au>Chan, Kwok Ting</au><au>Chan, Chloe Y. Y.</au><au>Cheng, H. C.</au><au>Yuen, Kamy M. Y.</au><au>Cai, Jing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife</atitle><jtitle>Frontiers in oncology</jtitle><date>2022-06-16</date><risdate>2022</risdate><volume>12</volume><spage>860641</spage><epage>860641</epage><pages>860641-860641</pages><issn>2234-943X</issn><eissn>2234-943X</eissn><abstract>PurposeFor the treatment of invisible lung tumours with CyberKnife (CK), fiducial markers (FMs) were implanted as an internal surrogate under virtual bronchoscopic navigation (VBN). This research aims to study the benefits of introducing an additional procedure in assigning the optimal FM positions using a pre-procedure planning system and performing virtual simulation before implantation. The objectives were 1) to reduce the duration of the FM implantation procedure, 2) to reduce the radiation exposure in dose area product (DAP) (dGy*cm2) to patients, and 3) to increase the number of FMs implanted around the tumour. Methods and MaterialsThis study is retrospective, single-centre, and observational in nature. A total of 32 patients were divided into two groups. In Group 1, 18 patients underwent conventional VBN FM implantation. In Group 2, 14 patients underwent additional pre-procedure planning and simulation. The steps of pre-procedure planning include 1) importing CT images into the treatment planning system (Eclipse, Varian Medical Systems, Inc.) and delineating five to six FMs in their ideal virtual positions and 2) copying the FM configuration into VBN planning software (LungPoint Bronchus Medical, Inc.) for verification and simulation. Finally, the verified FMs were deployed through VBN with the guidance of the LungPoint planning software. ResultsA total of 162 FMs were implanted among 35 lesions in 32 patients aged from 37 to 92 (median = 66; 16 men and 16 women). Results showed that 1) the average FM insertion time was shortened from 41 min (SD = 2.05) to 23 min (SD = 1.25), p = 0.00; 2) the average absorbed dose of patients in DAP was decreased from 67.4 cGy*cm2 (SD = 14.48) to 25.3 cGy*cm2 (SD = 3.82), p = 0.01 (1-tailed); and 3) the average number of FMs implanted around the tumour was increased from 4.7 (SD = 0.84) to 5.6 (SD = 0.76), p = 0.00 (1-tailed). ConclusionPre-procedure planning reduces the FM implantation duration from 41.1 to 22.9 min, reduces the radiation exposure in DAP from 67.4 to 25.3 dGy*cm2, and increases the number of FMs inserted around the tumour from 4.7 to 5.6.</abstract><pub>Frontiers Media S.A</pub><pmid>35785178</pmid><doi>10.3389/fonc.2022.860641</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2234-943X |
ispartof | Frontiers in oncology, 2022-06, Vol.12, p.860641-860641 |
issn | 2234-943X 2234-943X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_56c7fc4a27424e7cb3f464341229aa15 |
source | PMC (PubMed Central) |
subjects | CyberKnife dose area product fiducial marker lung cancer Oncology virtual bronchoscopic navigation |
title | Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T22%3A37%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Evaluation%20of%20Fiducial%20Marker%20Pre-Planning%20for%20Virtual%20Bronchoscopic%20Navigation%20Implantation%20in%20Lung%20Tumour%20Patients%20Treated%20With%20CyberKnife&rft.jtitle=Frontiers%20in%20oncology&rft.au=Ku,%20Ki%20Man&rft.date=2022-06-16&rft.volume=12&rft.spage=860641&rft.epage=860641&rft.pages=860641-860641&rft.issn=2234-943X&rft.eissn=2234-943X&rft_id=info:doi/10.3389/fonc.2022.860641&rft_dat=%3Cproquest_doaj_%3E2685031867%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c392t-247356141695ea6fe8a88b39bee82f21435dd29a2c99d487418af596ac4a111a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2685031867&rft_id=info:pmid/35785178&rfr_iscdi=true |